vinay prasad fda - Search News

News

FDA names Dr. Vinay Prasad

FDA names Dr. Vinay Prasad as top vaccine official

In his new role with the FDA, Dr. Vinay Prasad will oversee the regulation of costly drugs, including vaccines, gene therapies, and blood supply.

CNN on MSN · 2d

FDA chooses Dr. Vinay Prasad to lead biologics, vaccines division

The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics Evaluation and Research, the division that oversees vaccines and biologic medicines.

Vinay Prasad’s FDA Appointment ‘Anything but Status Quo’

The UCSF professor and frequent YouTube poster has criticized COVID-19 vaccine mandates as well as the accelerated approval pathway and other FDA practices. Predictions of what his tenure might achieve are scattershot.

Axios on MSN8h

Vinay Prasad believes that the FDA too often has acted as a rubber stamp for pharma, both big and small.

Biotech venture capital is risky business, inherently at the mercy of regulators and binary outcomes. Now it may face a new ...

BioPharma Dive8h

Biotech is guessing how Vinay Prasad might change the FDA. His research, writing offer clues.

CBER’s new chief has argued for more stringent measures of assessing drugs for cancer and rare diseases, suggesting he might ...

New CBER Director Vinay Prasad praises evidence, FDA reviewers in first speech to staff

WASHINGTON — In his first address to FDA staff on Wednesday, Vinay Prasad emphasized his commitment to evidence, his ...

The Lund Report3h

Former OHSU oncologist Vinay Prasad tapped by RFK Jr. to head FDA vaccine division

FDA commissioner Marty Makary told FDA staff in an email that Prasad, “brings a great set of skills, energy, and competence ...

1don MSN

The FDA names a new vaccine chief with an unsettling record, joining a controversial team

Dr. Vinay Prasad, the FDA's new vaccine chief, has been accused of spreading misinformation about Covid vaccines.

Trump taps MAHA influencer for surgeon general, Vinay Prasad’s first speech at FDA

This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results